Investigational Site Number :4100008

Incheon, Incheon-gwangyeoksi 21565

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

Studies at this site

• A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps — Running, not enrolling
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed